Musings from The Power List: Piers Ingram

• by Piers Ingram

• October 20, 2026

Screening strategies for the early detection of non-cardia gastric cancer in low- to moderate-prevalence regions: Asia-Pacific gastroesophageal cancer congress consensus 2026

• by Ayaka Takasu, Fumiaki Ishibashi, Rapat Pittayanon, Hon Chi Yip, James Weiquan Li, Munkhsaruul Bayaraa, Hyunsoo Chung, Do Hoon Kim, Kamin Harinwan, Quang Dinh Le, Adolfo Parra-Blanco, Paulo Kassab, Vincenzo Giorgio Mirante, José Murillo-Rodriguez, Regina Rie Imada, Renata Nobre Moura, Sabina Beg, Pedro Genaro Delgado-Guillena, Marta Rodriguez-Carrasco, Seung-Hun Chon, Chul S. Hyun, Grigorios Christodoulidis, Vo Duy Long, Zili Xiao, Sergey Kashin, Roman Kuvaev, Ian Yu-Hong Wong, Robert Bechara, Mitsuru Esaki, Waku Hatta, Motohiko Kato, Seiichiro Abe, Sho Suzuki, Kohei Takizawa, Joo Ha Hwang, Wai Keung Leung, Duc Trong Quach, Matsuda Satoru, Han-Kwang Yang, Takuji Gotoda

• October 14, 2026

2026 ASCO Breast Cancer Highlights: SENOMAC

Harold Burstein, MD, PhD, and Laura S. Dominici, MD, FACS, discuss highlights from the SENOMAC trial which sheds light on whether some patients with early breast cancer and limited lymph node involvement can safely avoid additional axillary surgery.

• October 15, 2026

• 1 min

Final analysis results from DREAMM-3, a phase 3 study of belantamab mafodotin versus pomalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma

• by Meletios Athanasios Dimopoulos, Vania Hungria, Haitao Meng, Atanas Radinoff, Jian Li, Sosana Delimpasi, Ting Niu, Gabor Mikala, Tamas Masszi, Marcelo Capra, Michael Low, Angelo Maiolino, Yan Xu, Xavier Leleu, Vasiliki Pappa, Dominik Chraniuk, Tatiana Konstantinova, Iurii Osipov, Shawn Hakim, Chris Brawley, Gabriela Tubel, Astrid McKeown, Julia Boyle, Sumita Roy-Ghanta, Katja Weisel

• October 17, 2026